PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2026European Heart Journal Supplements0 citations

Prognosis and evolution of tricuspid regurgitation in patients undergoing percutaneous mitral repair for severe mitral regurgitation

View Full Paper
NKN KaramRFR F FouresCGC G Gallen

Key Result

Severe pre-procedural tricuspid regurgitation in patients undergoing mitral edge-to-edge repair is associated with lower 2-year survival (p=0.02) and higher 6-month NYHA III/IV rates (27.3% vs 6.1%).

Key Points

  • This research aims to examine the impact of tricuspid regurgitation on patient outcomes after mitral edge-to-edge repair.
  • Retrospective, observational study design
  • Included 98 patients undergoing mitral edge-to-edge repair
  • Treatment using MitraClip® between 2016 and 2022
  • Comparison of outcomes based on pre-procedural TR severity
  • Assessment of 6-month and long-term follow-up results
  • Patients with severe pre-procedural TR had worse symptoms at 6 months (27.3% NYHA III or IV) compared to those with TR <3 (6.1%)
  • Lower 2-year survival rates observed in patients with severe TR (p = 0.02)
  • Initial improvement in TR severity noted, increasing from 88.3% TR <3 at baseline to 95.2% at 6 months
  • Long-term follow-up showed TR severity similar to baseline in patients with severe TR grade.

Structured PICO

Does baseline severe tricuspid regurgitation worsen prognosis in patients undergoing percutaneous mitral edge-to-edge repair for severe mitral regurgitation?

P
Population
98 patients with severe mitral regurgitation who underwent mitral edge-to-edge repair using the MitraClip device between 2016 and 2022 at a French Hospital.
I
Intervention
Mitral edge-to-edge repair (mTEER) using the MitraClip device
C
Comparator
Patients with baseline tricuspid regurgitation (TR) grade <3 vs. patients with baseline TR grade ≥3
O
Outcome
Patient prognosis (2-year survival) and evolution of TR severityhard clinical

Severe baseline tricuspid regurgitation is associated with worse 2-year survival and higher symptom burden in patients undergoing mitral edge-to-edge repair, despite transient early improvement in TR severity.

Limitations

  • Retrospective, observational design
  • Single-center study

Abstract

Abstract Introduction Tricuspid regurgitation (TR) is a common encounter in patients with severe mitral regurgitation. With the advent of percutaneous treatment, discussions have been ongoing regarding the indication for combined mitral and tricuspid repair vs. staged treatment in case of TR persistence after mitral treatment. Purpose To assess the evolution and impact of TR on patient’s outcome after mitral edge-to-edge repair. Methods This retrospective, observational study included 98 patients who underwent mitral edge-to-edge repair using the MitraClip® device between 2016 and 2022 at a French Hospital. Patients’s prognosis according to the presence or absence of TR grade ≥3, and the evolution of TR was assessed in the global population, with a comparison according to baseline TR severity. Results Patients with severe pre-procedural TR were more symptomatic at 6-mths follow-up (NYHA III or. IV in 27.3% vs. 6.1% in patients with TR grade 3); the also demonstrated significantly lower 2-year survival rates (p = 0.02). TR severity initially improved in the overall population, with the proportion of patients with TR grade 3 increasing from 88.3% at baseline to 93.1% after the procedure and 95.2% at 6-month follow-up. However, TR severity appeared similar to baseline at long-term follow-up. In patients with baseline TR grade ≥ 3, TR severity showed early improvement following mTEER (63.6% at baseline, 30.0% at 6-mths follow-up, with an increase at long-term follow-up to 40%). Conclusion The presence of severe TR is associated with worse prognosis in patients undergoing mitral edge-to-edge repair for severe MR. Although there is an initial improvement in TR severity following the procedure, this benefit appears to diminish by 6 months. These findings raise important considerations regarding the potential need for concomitant or early staged management of severe TR alongside mitral valve intervention.For image description, please refer to the figure legend and surrounding text. Evolution of TR gradeFor image description, please refer to the figure legend and surrounding text.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Karam et al. (2026) studied this question. Severe pre-procedural tricuspid regurgitation in patients undergoing mitral edge-to-edge repair is associated with lower 2-year survival (p=0.02) and higher 6-month NYHA III/IV rates (27.3% vs 6.1%).

synapsesocial.com/papers/69ccb6ce16edfba7beb888e6https://doi.org/10.1093/eurheartjsupp/suag056.082
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Implications of Tricuspid Regurgitation Severity in Patients Undergoing Mitral Transcatheter Edge‐to‐Edge Repair2024 · 4 citations
  2. 2Concomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repair2021 · 42 citations
  3. 3Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair2021 · 46 citations
  4. 4Impact of concomitant tricuspid regurgitation on outcome after edge‐to‐edge mitral valve repair2023 · 2 citations
  5. 5Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair2017 · 53 citations